CluePoints

What we do: CluePoints is a leading provider of Risk-Based Quality Management (RBQM) and data quality oversight software for clinical trials. Leveraging advanced statistics, artificial intelligence, and machine learning, CluePoints’ platform ensures the quality, accuracy, and integrity of clinical trial data throughout the study lifecycle. Their solutions support central and on-site monitoring, medical review, and quality risk management aligned with regulatory guidance from FDA, EMA, ICH, and MHRA. The company serves pharmaceutical and biotech companies, contract research organizations, and other clinical trial stakeholders to improve trial efficiency, reduce costs, and mitigate regulatory risks.

Where we are located: CluePoints is headquartered at the New Tech Centre, 1348 Avenue Albert Einstein 2A, Louvain-La-Neuve, Belgium.

Short history: Founded in 2012, CluePoints has grown to become a premier software provider in the RBQM space. The company has developed proprietary AI-driven algorithms and statistical methods to support over 9,500 platform users and has helped de-risk more than 1,600 clinical studies globally. It has attracted significant investment from EQT and other partners to expand its market leadership.

Organization & culture: CluePoints is a technology-driven company focused on innovation in clinical trial risk management. While specific details on company size and culture are not publicly detailed, the firm emphasizes thought leadership, consulting expertise, and a collaborative approach to delivering smarter clinical trial solutions.